by Jordana Choucair | Dec 3, 2021 | Life Sciences
The FDA is preparing to accelerate the review of vaccines and drugs targeting the omicron variant in case they’re needed. According to people familiar with the matter, agency officials are meeting with drugmakers and establishing guidelines for research. Vaccine...
by Jordana Choucair | Dec 3, 2021 | Life Sciences
Robert Califf, President Biden’s nominee to lead the FDA, asked Dr. Janet Woodcock, the agency’s acting commissioner, to stay on if he’s confirmed by the Senate. The Senate has not yet set a confirmation hearing for Califf. It is also not yet clear...
by Jordana Choucair | Dec 3, 2021 | Mental Health
A new Gallup poll found that the percentage of Americans who rate their mental health as “excellent” remains at a two-decade low. The results are similar to a poll conducted last year. However, the poll did find a five-percent increase in the percentage of Americans...
by Jordana Choucair | Dec 3, 2021 | Payers
A new Urban Institute report estimates that 13 million adults delayed getting or didn’t fill prescription drugs prior to the COVID-19 pandemic due to cost. Nearly 10 percent of Americans who were uninsured all year reported unmet prescription drug needs,...
by Jordana Choucair | Dec 3, 2021 | Public Health/Prevention
World Health Organization (WHO) officials said that measures used to combat the COVID-19 delta variant should be kept in place to counter omicron. The group previously cautioned against border closures, but Dr. Takeshi Kasai, the WHO regional director for the Western...
by Jordana Choucair | Dec 2, 2021 | Life Sciences
A federal appeals court on Wednesday dismissed two patent challenges from Moderna over key components involved in making its COVID-19 vaccine. The court’s decision to side with Canadian biopharmaceutical company Arbutus Biopharma Corporation means Arbutus...
Recent Comments